September 18, 2018
FluroTech (TSXV:TEST), (“FluroTech” or the “Company”), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development. With prior industry experience at Aurora Cannabis Inc., Dr. MacMillan brings with him an impressive background in plant breeding, biotechnology regulatory environments and quality control. He will be an integral part of [...]
September 18, 2018
Boston, Mass. and Indianapolis, Ind. — BioBright and Beckman Coulter announce a strategic partnership to bring enhanced technical support capabilities to instruments. BioBright’s DarwinSync platform gives Beckman Coulter access to a large amount of precise data about deployed instrument logs, enabling faster troubleshooting, reduced equipment downtime, and predictive analytics. Beckman Coulter will deploy BioBright’s DarwinSync platform to multiple [...]
ASPECT BIOSYSTEMS ANNOUNCES LIVER TISSUE COLLABORATION WITH JSR
September 18, 2018
Vancouver, Canada - Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, is pleased to announce a new collaboration to develop human liver tissue with JSR Corporation, a leading materials supplier in a variety of technology driven markets.Through this collaboration, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform and JSR’s advanced materials technology will [...]
Thermo Fisher Scientific Expands Genome Editing IP Portfolio
September 18, 2018
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif. -- Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio. Under the terms of [...]
Circulating Tumor DNA Reference Standards
September 18, 2018
AMSBIO announce the launch of a new range of circulating tumor DNA (ctDNA) Reference Standards for cancer disease management research. A critical goal in cancer disease management is early detection. When detected early, cancer progression can be arrested using techniques such as targeted therapy, chemotherapy and surgery thereby increasing the chances of survival and a [...]
Genovis launches FabRICATOR®-HPLC for automated antibody analysis
September 18, 2018
Today Genovis is initiating sales of the FabRICATOR-HPLC column for quality assessment of antibodies in automated analytical systems. The product is based on Genovis’ FabRICATOR technology and can be used in existing analytical systems for rapid online analysis without manual sample handling. FabRICATOR HPLC is a column that enables automated analysis of therapeutic antibodies during development, production and formulation of antibody-based drugs. [...]
PathSensors Reaches Japan Through Partnership With Ensensor
September 17, 2018
BALTIMORE -- PathSensors and Ensensor Japan have entered into a partnership to bring novel pathogen detection devices to markets in Japan. Ensensor is a bio-detection company created in joint venture with S.T. Japan, a well-known organization that specializes in selling products such as spectra databases, microscopy accessories, and analytical instruments. The company has become a distributor of PathSensors' CANARY [...]
Golden Helix Receives NIH-SBIR Phase 2 Grant 2R44 GM125432-02
September 17, 2018
Integrating CNV analysis into a NextGen sequencing clinical analytics platform Bozeman, MT — Golden Helix, Inc., an industry-leading genomic analytics company that specializes in clinical Next-Gen Sequencing analysis software, has announced today that the National Institutes of Health awarded them a Phase 2 SBIR Grant 2R44 GM125432-02 “Integrating CNV analysis into a NextGen sequencing clinical analytics [...]
September 17, 2018
CE-marked workflow enables efficient, high-throughput screening for tuberculosis control efforts in Europe and other markets; introduction in United States expected in 2019 and China in 2020 Hilden, Germany, and Saluggia, Italy – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE Italy Mid Cap: DIA) today announced the introduction of an automated, CE-marked workflow [...]
Thompson Street Capital Partners Acquires LifeSpan Biosciences, Inc.
September 17, 2018
ST. LOUIS – Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc., (LSBio). The Company is a founder-led developer and distributor of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform. Terms of the [...]

